Human Gene MELK (ENST00000298048.7) from GENCODE V44
  Description: Homo sapiens maternal embryonic leucine zipper kinase (MELK), transcript variant 1, mRNA. (from RefSeq NM_014791)
Gencode Transcript: ENST00000298048.7
Gencode Gene: ENSG00000165304.8
Transcript (Including UTRs)
   Position: hg38 chr9:36,572,895-36,677,682 Size: 104,788 Total Exon Count: 18 Strand: +
Coding Region
   Position: hg38 chr9:36,581,682-36,677,337 Size: 95,656 Coding Exon Count: 17 

Page IndexSequence and LinksUniProtKB CommentsPrimersCTDRNA-Seq Expression
Microarray ExpressionRNA StructureProtein StructureOther SpeciesGO AnnotationsmRNA Descriptions
Other NamesMethods
Data last updated at UCSC: 2023-08-18 00:09:47

-  Sequence and Links to Tools and Databases
 
Genomic Sequence (chr9:36,572,895-36,677,682)mRNA (may differ from genome)Protein (651 aa)
Gene SorterGenome BrowserOther Species FASTAGene interactionsTable SchemaAlphaFold
BioGPSEnsemblEntrez GeneExonPrimerGencodeGeneCards
HGNCHPRDLynxMGIneXtProtOMIM
PubMedUniProtKBWikipediaBioGrid CRISPR DB

-  Comments and Description Text from UniProtKB
  ID: MELK_HUMAN
DESCRIPTION: RecName: Full=Maternal embryonic leucine zipper kinase; Short=hMELK; EC=2.7.11.1; AltName: Full=Protein kinase Eg3; Short=pEg3 kinase; AltName: Full=Protein kinase PK38; Short=hPK38; AltName: Full=Tyrosine-protein kinase MELK; EC=2.7.10.2;
FUNCTION: Serine/threonine-protein kinase involved in various processes such as cell cycle regulation, self-renewal of stem cells, apoptosis and splicing regulation. Has a broad substrate specificity; phosphorylates BCL2L14, CDC25B, MAP3K5/ASK1 and ZNF622. Acts as an activator of apoptosis by phosphorylating and activating MAP3K5/ASK1. Acts as a regulator of cell cycle, notably by mediating phosphorylation of CDC25B, promoting localization of CDC25B to the centrosome and the spindle poles during mitosis. Plays a key role in cell proliferation and carcinogenesis. Required for proliferation of embryonic and postnatal multipotent neural progenitors. Phosphorylates and inhibits BCL2L14, possibly leading to affect mammary carcinogenesis by mediating inhibition of the pro-apoptotic function of BCL2L14. Also involved in the inhibition of spliceosome assembly during mitosis by phosphorylating ZNF622, thereby contributing to its redirection to the nucleus. May also play a role in primitive hematopoiesis.
CATALYTIC ACTIVITY: ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate.
CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
ENZYME REGULATION: Activated by autophosphorylation of the T-loop at Thr-167 and Ser-171: in contrast to other members of the SNF1 subfamily, phosphorylation at Thr-167 is not mediated by STK11/LKB1 but via autophosphorylation instead. Inhibited by calcium-binding. Kinase activity is also regulated by reducing agents: dithiothreitol (DTT) or reduced glutathione are required for kinase activity in vitro; such dependence is however not due to the presence of disulfide bonds.
SUBUNIT: Monomer. Interacts with ZNF622 and PPP1R8.
INTERACTION: Q9BZR8:BCL2L14; NbExp=4; IntAct=EBI-1046702, EBI-1385773;
SUBCELLULAR LOCATION: Cell membrane; Peripheral membrane protein.
TISSUE SPECIFICITY: Expressed in placenta, kidney, thymus, testis, ovary and intestine.
DEVELOPMENTAL STAGE: Increases during G2/M phase compared to interphase. Protein level decreases when cells exit mitosis, probably due to degradation.
INDUCTION: Up-regulated in many cancers cells. Up-regulated upon treatment with radiation or 5-fluorouracil (5-FU) in colorectal cancer cells, suggesting that it might be associated with increased resistance of colorectal cells against radiation and 5- FU. Down-regulated upon siomycin A, a thiazole antibiotic, treatment, leading to inhibit tumor growth in vivo.
DOMAIN: The KA1 domain mediates binding to phospholipids and targeting to membranes (By similarity).
PTM: Autophosphorylated: autophosphorylation of the T-loop at Thr- 167 and Ser-171 is required for activation. Thr-478 phosphorylation during mitosis promotes interaction with PPP1R8 (Probable).
DISEASE: Note=Defects in MELK are associated with some cancers, such as brain or breast cancers. Expression is dramatically increased in aggressive undifferentiated tumors, correlating with poor patient outcome in breast and brain cancers, suggesting a role in tumor-initiating cells and proliferation via its function in cell proliferation regulation.
MISCELLANEOUS: Potential therapeutic target for treatment of somatic tumors, such as brain and breast cancers, down-regulation of MELK inhibiting tumorigenesis (PubMed:17960622, PubMed:20861186).
SIMILARITY: Belongs to the protein kinase superfamily. CAMK Ser/Thr protein kinase family. SNF1 subfamily.
SIMILARITY: Contains 1 KA1 (kinase-associated) domain.
SIMILARITY: Contains 1 protein kinase domain.
SEQUENCE CAUTION: Sequence=BAA11492.2; Type=Erroneous initiation; Note=Translation N-terminally shortened;

-  Primer design for this transcript
 

Primer3Plus can design qPCR Primers that straddle exon-exon-junctions, which amplify only cDNA, not genomic DNA.
Click here to load the transcript sequence and exon structure into Primer3Plus

Exonprimer can design one pair of Sanger sequencing primers around every exon, located in non-genic sequence.
Click here to open Exonprimer with this transcript

To design primers for a non-coding sequence, zoom to a region of interest and select from the drop-down menu: View > In External Tools > Primer3


-  Comparative Toxicogenomics Database (CTD)
  The following chemicals interact with this gene           more ... click here to view the complete list

-  RNA-Seq Expression Data from GTEx (53 Tissues, 570 Donors)
  Highest median expression: 16.48 RPKM in Cells - EBV-transformed lymphocytes
Total median expression: 42.17 RPKM



View in GTEx track of Genome Browser    View at GTEx portal     View GTEx Body Map

+  Microarray Expression Data
  Press "+" in the title bar above to open this section.

-  mRNA Secondary Structure of 3' and 5' UTRs
 
RegionFold EnergyBasesEnergy/Base
Display As
5' UTR -43.30151-0.287 Picture PostScript Text
3' UTR -71.20345-0.206 Picture PostScript Text

The RNAfold program from the Vienna RNA Package is used to perform the secondary structure predictions and folding calculations. The estimated folding energy is in kcal/mol. The more negative the energy, the more secondary structure the RNA is likely to have.

-  Protein Domain and Structure Information
  InterPro Domains: Graphical view of domain structure
IPR001772 - Kinase-assoc_KA1
IPR011009 - Kinase-like_dom
IPR000719 - Prot_kinase_cat_dom
IPR017441 - Protein_kinase_ATP_BS
IPR002290 - Ser/Thr_dual-sp_kinase_dom
IPR008271 - Ser/Thr_kinase_AS

Pfam Domains:
PF02149 - Kinase associated domain 1
PF00069 - Protein kinase domain

ModBase Predicted Comparative 3D Structure on Q14680
FrontTopSide
The pictures above may be empty if there is no ModBase structure for the protein. The ModBase structure frequently covers just a fragment of the protein. You may be asked to log onto ModBase the first time you click on the pictures. It is simplest after logging in to just click on the picture again to get to the specific info on that model.

-  Orthologous Genes in Other Species
  Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
MouseRatZebrafishD. melanogasterC. elegansS. cerevisiae
Genome BrowserGenome BrowserGenome BrowserNo orthologGenome BrowserNo ortholog
Gene Details     
Gene Sorter     
MGIRGDEnsembl WormBase 
Protein SequenceProtein SequenceProtein Sequence Protein Sequence 
AlignmentAlignmentAlignment Alignment 

-  Gene Ontology (GO) Annotations with Structured Vocabulary
  Molecular Function:
GO:0000166 nucleotide binding
GO:0004672 protein kinase activity
GO:0004674 protein serine/threonine kinase activity
GO:0004715 non-membrane spanning protein tyrosine kinase activity
GO:0005509 calcium ion binding
GO:0005515 protein binding
GO:0005524 ATP binding
GO:0008289 lipid binding
GO:0016301 kinase activity
GO:0016740 transferase activity

Biological Process:
GO:0000086 G2/M transition of mitotic cell cycle
GO:0006468 protein phosphorylation
GO:0006915 apoptotic process
GO:0007049 cell cycle
GO:0008283 cell proliferation
GO:0008631 intrinsic apoptotic signaling pathway in response to oxidative stress
GO:0016310 phosphorylation
GO:0018108 peptidyl-tyrosine phosphorylation
GO:0030097 hemopoiesis
GO:0035556 intracellular signal transduction
GO:0043065 positive regulation of apoptotic process
GO:0046777 protein autophosphorylation
GO:0061351 neural precursor cell proliferation

Cellular Component:
GO:0005634 nucleus
GO:0005737 cytoplasm
GO:0005886 plasma membrane
GO:0005938 cell cortex
GO:0016020 membrane


-  Descriptions from all associated GenBank mRNAs
  KJ904636 - Synthetic construct Homo sapiens clone ccsbBroadEn_14030 MELK-like gene, encodes complete protein.
AK296820 - Homo sapiens cDNA FLJ51888 complete cds, highly similar to Maternal embryonic leucine zipper kinase (EC 2.7.11.1).
AK222811 - Homo sapiens mRNA for maternal embryonic leucine zipper kinase variant, clone: HEP06833.
D79997 - Homo sapiens KIAA0175 mRNA.
JD114621 - Sequence 95645 from Patent EP1572962.
AK302374 - Homo sapiens cDNA FLJ55288 complete cds, highly similar to Maternal embryonic leucine zipper kinase (EC2.7.11.1).
AK293423 - Homo sapiens cDNA FLJ50443 complete cds, highly similar to Maternal embryonic leucine zipper kinase (EC 2.7.11.1).
AK300761 - Homo sapiens cDNA FLJ50690 complete cds, highly similar to Maternal embryonic leucine zipper kinase (EC 2.7.11.1).
AK293284 - Homo sapiens cDNA FLJ50438 complete cds, highly similar to Maternal embryonic leucine zipper kinase (EC 2.7.11.1).
AK309470 - Homo sapiens cDNA, FLJ99511.
AK293447 - Homo sapiens cDNA FLJ50445 complete cds, highly similar to Maternal embryonic leucine zipper kinase (EC 2.7.11.1).
BC014039 - Homo sapiens maternal embryonic leucine zipper kinase, mRNA (cDNA clone MGC:20350 IMAGE:4547136), complete cds.
LF383865 - JP 2014500723-A/191368: Polycomb-Associated Non-Coding RNAs.
MA619442 - JP 2018138019-A/191368: Polycomb-Associated Non-Coding RNAs.
AB183428 - Homo sapiens MELKv3 mRNA for maternal embryonic luecine zipper kinase v3, complete cds.
AK300821 - Homo sapiens cDNA FLJ54386 complete cds, highly similar to Maternal embryonic leucine zipper kinase (EC 2.7.11.1).
AK299164 - Homo sapiens cDNA FLJ61344 complete cds, highly similar to Maternal embryonic leucine zipper kinase (EC 2.7.11.1).
AB183427 - Homo sapiens MELKv2 mRNA for maternal embryonic leucine zipper kinase v2, complete cds.
AK301131 - Homo sapiens cDNA FLJ55799 complete cds, highly similar to Maternal embryonic leucine zipper kinase (EC 2.7.11.1).
JD317308 - Sequence 298332 from Patent EP1572962.
LF354423 - JP 2014500723-A/161926: Polycomb-Associated Non-Coding RNAs.
MA590000 - JP 2018138019-A/161926: Polycomb-Associated Non-Coding RNAs.
LF354434 - JP 2014500723-A/161937: Polycomb-Associated Non-Coding RNAs.
MA590011 - JP 2018138019-A/161937: Polycomb-Associated Non-Coding RNAs.
AB267395 - Homo sapiens MELKV4 mRNA for maternal embryonic luecine zipper kinase v4, complete cds.
LF354442 - JP 2014500723-A/161945: Polycomb-Associated Non-Coding RNAs.
MA590019 - JP 2018138019-A/161945: Polycomb-Associated Non-Coding RNAs.
JD458881 - Sequence 439905 from Patent EP1572962.

-  Other Names for This Gene
  Alternate Gene Symbols: B1AMQ6, D3DRP8, ENST00000298048.1, ENST00000298048.2, ENST00000298048.3, ENST00000298048.4, ENST00000298048.5, ENST00000298048.6, KIAA0175, MELK_HUMAN, NM_014791, Q14680, Q7L3C3, uc003zzn.1, uc003zzn.2, uc003zzn.3, uc003zzn.4, uc003zzn.5, uc003zzn.6
UCSC ID: ENST00000298048.7
RefSeq Accession: NM_014791
Protein: Q14680 (aka MELK_HUMAN)
CCDS: CCDS59126.1, CCDS6606.1

-  Methods, Credits, and Use Restrictions
  Click here for details on how this gene model was made and data restrictions if any.